Delayed Coronary Obstruction After TAVR: A Complication We Had Not Considered

Delayed coronary obstruction (after TAVR, outside the cath lab) is a rare complication with high mortality rates, not unlike acute obstruction. Cardiologists should be expectant and, upon the slightest suspicion of this complication, patients should be brought back to the cath lab for a coronary angiography.

Transcatheter Valve Replacement in the Bicuspid Valve Is Increasingly Performed, but Challenges RemainOcclusion immediately after implant release has been well-studied and described (risk factors, prevention techniques, more akin devices, etc.), but we ignored that this event can take place even months after the procedure.

 

Data for this work were retrospectively collected from an international multicenter registry between 2005 and 2016.

 

During the study period, 38 delayed coronary obstructions (incidence 0.22%) were observed after TAVR from a total of 17,092 patients. Occlusions were more common after valve-in-valve procedures (0.89% vs. 0.18%; p < 0.001) and in cases in which self-expandable valves were used during the index procedure (0.36% vs. 0.11% for balloon-expandable; p < 0.01).


Read also: Permanent Pacemaker: still TAVR’s Aquila’s Heel.


Delayed occlusion was most frequent within 24 hours from the procedure (47.4%; n = 18); 6 (15.8%) cases occurred between 24 hours and 7 days, and the remaining 14 (36.8%) occurred within 60 days.

 

The most frequent presentation was cardiac arrest (31.6%), followed by ST-segment elevation myocardial infarction (23.7%; n = 9). The left coronary artery was the culprit vessel in most cases (92.1%).

 

Stent implantation in this registry was successful in about 70% of all patients, thus indicating that angioplasty should be attempted whenever possible.


Read also: Which Low-Flow, Low-Gradient Patients Benefit from Valve Replacement?


In-hospital mortality reached 50% and was higher among patients who experienced the event within 7 days from the index procedure (62.5% vs. 28.6%; p = 0.09).

 

Conclusion

Delayed coronary occlusion following TAVR is a rare phenomenon with an extremely high mortality rate. Angioplasty should be attempted whenever possible, since stent implantation was successful in about 70% of all cases.

 

Original title: Delayed Coronary Obstruction After Transcatheter Aortic Valve Replacement.

Reference: Richard J. Jabbour et al. J Am Coll Cardiol 2018;71:1513-24.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers

Multiple randomized studies have shown comparable or superior efficacy of transcatheter aortic valve replacement (TAVR) vs. coronary artery bypass graft (CABG).  However, many of...

TCT 2024 | TRISCEND II: A New Hope in Percutaneous Tricuspid Valve Replacement

Advanced tricuspid regurgitation (TR) is a debilitating disease associated with heart failure and increased mortality.  Edge-to-edge repair has been shown to improve both clinical condition...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....